Table 4. Clinical data during liver transplantation in patients receiving a IP and non-IP allograft.

	Non-steatotic allografts		Steatosic allografts
Variable	IP (n=14) group I	Non-IP (n=14) group II	IP (n=12) group III	Non-IP (n=10) group IV	P-value I versus IIa	P-value III versus IVa	P-value I versus IIIa	P-value II versus IVa
Hepatic function
AST at day 5 (IU/l)	42±33	79±57	55±40	139±164	0.047	0.10	0.37	0.22
ALT at day 5 (IU/l)	82±39	247±194	222±246	423±409	0.005	0.17	0.046	0.17
AST peak (IU/l)	235±189	458±308	881±1323	862±762	0.029	0.96	0.08	0.09
ALT peak (IU/l)	187±94	577±361	795±796	728±724	0.0006	0.84	0.009	0.51
PT (%) at day 5	61±13	67±10	63±20	68±9	0.18	0.48	0.73	0.74
Bilirubin at day 7 (μmol/l)	46±44	38±21	106±148	78±45	0.55	0.57	0.16	0.007
Hospitalization
Intensive care unit stay (days)	12±7	11±6	15±10	12±5	0.67	0.42	0.47	0.59
Total stay in hospital (days)	28±8	29±13	52±43	33±9	0.70	0.18	0.049	0.53
Retransplantation	1/14	1/14	0/12	0/10	—	—	0.52	0.52
Rejection
Acute rejection	2/14	5/14	2/12	6/10	0.15	0.048	0.40	0.17
Rejection activity index (mean±S.D.)	5±1.4	5.2±1.3	5±1.7	4.7±0.9	0.86	0.73	1.00	0.66
Acute rejection delay (median in month)	0.5	1.25	0.5	2	0.84	0.92	0.99	0.99
Chronic rejection	0/14	2/14	2/12	7/10	0.24	0.017	0.20	0.009
Ductopenia (mean±S.D. in %)	—	44.5±15.6	49.7±23.1	36.5±10.2	—	0.15	—	0.22
Chronic rejection delay (median in month)	—	42	9	36	—	0.09	—	1.00
Follow-up (mean±S.D. in months)	53±18	60±30	47±27	64±26	0.44	0.16	0.51	0.76

^aMeans were compared using the Student's t-test

Dichotomous variables were compared using the Fisher exact test

Medians were compared with Kolmogorov–Smirnov test